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Abstract
Background: Jacobsen syndrome (JBS) is a contiguous gene deletion syndrome involving 11q terminal deletion.
Interstitial deletions at distal 11q are rare and their contributions to the clinical phenotype of JBS are unknown.
Case presentation: We presented the chromosome microarray (CMA) data and the clinical features of two individuals
carrying a non-overlapping de novo deletion each at the 11q23.3-q24.2 region in an effort to analyze the correlation
between region of deletion at 11q and phenotype. Both deletions are likely pathogenic for patient’s condition. The
deletion at 11q23.3q24.1 is associated with short stature, relative microcephaly, failure to thrive, hypotonia and sleeping
disorder. The deletion at 11q24.2 involves HEPACAM and our patient’s clinical presentation (relative macrocephaly,
abnormal MRI, mild developmental delay and seizure) is not inconsistent with Megalencephalic leukoencephalopathy
with subcortical cysts 2B.
Conclusions: Our finds support the notion that more than one critical region at 11q23.3-qter are responsible for the
variable clinical presentation of JBS, thus JBS is a true contiguous gene deletion syndrome where multiple loci
contributed to the clinical characteristics of JBS. Small interstitial deletions at 11q23.3-q24.2 and their associated
unique features also suggest emerging novel genomic disorders.
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Background
The 11q terminal deletion, also known as Jacobsen syn-
drome (OMIM #147791), is a contiguous gene deletion
syndrome involving the deletion of 11qter. Several hun-
dred 11q terminal deletion patients had been described
since it was first reported by Jacobsen in 1973 [1]. The
deletions observed in JBS patients range from 7 to
20 Mb in size and are almost always associated with 11q
terminal deletions and the furthest breakpoint is located
at 11q23.3. Typical features of JBS include developmen-
tal delay (DD)/intellectual disability (ID), dysmorphic fa-
cial features, platelet disorder and multiple congenital
defects [1–6]. Interstitial deletions from 11q23 to 11qter
are rare and their clinical significance is currently un-
known. Some of previously reported 11q23-qter intersti-
tial deletions were characterized by karyotyping analysis
[7–9]. CMA analysis made it possible to better define
the genotype–phenotype correlation. Since the first re-
port of an 11q24.1q24.3 interstitial deletion character-
ized by CMA [10], eight cases with 11q23-qter
interstitial deletion detected by CMA had been docu-
mented in literature (see Additional file 1: Table S1).
The breakpoints of the 11q23-qter interstitial deletions
are variable and deletions range from 2.89 to 12.8 Mb in
size. Clinical presentations of affected individuals are
also very heterogeneous, thus complicating the geno-
type–phenotype correlation analysis [4, 5, 10–14]. Pa-
tient with interstitial deletion at 11q23-qter region could
share some of the JBS features such as hypotonia [9],
macrocephaly [11, 14], microcephaly [5], trigonocephaly
[4, 7, 9], some of dysmorphic facial features [4, 5, 7–14],
limbs anomalies [7, 11, 13], congenital heart defect
(CHD) [4, 5, 7, 9, 10, 12], but often did not exhibit the
whole constellation of JBS [13, 14]. The most consistent
feature among all patients with 11q23-qter interstitial
deletion is DD/ID. Smallest overlapping regions helped
to define some critical regions or candidate genes at the
distal 11q region [4–11].
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Here, we reported two individuals carrying non-
overlapping interstitial deletions at 11q23.3-q24.2 region
with different degrees of DD/ID and some dysmorphic




Patient 1 (P1) was a 5-year-old girl born to a 29-year-old
woman at 41 weeks of gestational age. Pregnancy and
delivery were uneventful. Her birth weight was 2.8 kg
(~15thpercentile) and birth length around 48.2 cm
(~15thpercentile). She had an apparently healthy twin
brother and sister. At around 5–6 months of age she
was noticed to have global delay including unable to roll
over, delayed crawling, sitting and standing. She was at a
5-month developmental level at the age of one. She had
a history of failure to thrive and hypotonia. She came to
Genetics Clinic due to dysmorphic features and global
developmental delay. At 5-years of age, her height was
101 cm (−2.11 SD), weight 14 kg (−2.58 SD) and head
circumference 48.3 cm (7th percentile). She had overlap-
ping toes, dysmorphic features including mild hyperte-
lorism (inner canthal distance 27 mm, +1SD), prominent
forehead, flat facial profile, broad nose, smooth philtrum
with thin upper lip, upslanting palpebral fissures with
epicanthal folds. Her brain MRI was normal. No other
defect was noticed.
She had a history of sleeping disorder. Notably, her
parents reported that she would vocalize around bed-
time, often it is associated with body rocking and head
banging. She would wake up and bang her head at mid-
night. She would sit Indian style on her bed and leaned
forward until she banged her head on the mattress. This
occurred in a fairly fast and rhythmic pattern. Often she
would moan during such a movement and many times
the moan escalated into very loud scream. She also had
the rocking behavior during the daytime that she would
move her back up against a hard surface and then
rocked her lower back and buttocks on the floor. She
was diagnosed as jactatio capitis nocturna and such be-
havior had improved but not resolved entirely.
Patient 2
Patient 2 (P2) was a boy who came to hospital due to
fever, mild developmental delay and seizure at the age of
10 months. He was a full term second child to a healthy
parent who had a healthy 4-year-elder daughter. He was
delivered via cesarean section without complication dur-
ing pregnancy or delivery. His birth weight was 3.25 kg
(25–50th percentile) and birth length was 50 cm (25–
50th percentile). He had no significant medical history
prior to presentation. No family history of seizure, autism,
mental retardation or other neurologic impairments. He
raised his head around 3–4 months of age, rolled over
around 6–7 months of age, and pronounced first word at
about 10 months of age. His developmental quotient (DQ)
and the mental index (MI) suggested that he had mild de-
velopment delay by the Denver Development Screening
Test score (DQ = 51 and MI = 63). At the age of
10 months, his weight was 9.4 kg (30th percentile) and
height 72.5 cm (25th percentile). He presented with a rela-
tive macrocephaly (circumference was 47.5 cm (+1.3SD)),
mild hypertelorism, low nasal bridge, thin upper lip and
strabismus. The magnetic resonance imaging (MRI) re-
vealed the widening of the frontotemporal lobe, full bilat-
eral ventricles and deep parietal sulci. He had normal
electroencephalogram and electromyography. He was di-
agnosed with acute pharyngitis, secondary seizure, psy-
chomotor retardation and mild development delay as well
as cerebral hypogenesis.
Method
Chromosomal microarray (CMA) analyses
DNA sample was extracted from peripheral blood lym-
phocytes using standard protocol, microarray was per-
formed using Agilent 244 K array for patient 1 and the
illumina HumanSNP cyto-12 array for patient 2.
Results
A 1.6 Mb deletion at the region of 11q23.3-q24.1
(chr11:120410050–122085906) (hg19) was detected in
the genome of P1. A 0.76 Mb deletion at 11q24.2
(chr11:124635144–125390604) (hg19) was detected in
the genome of P2 (Fig. 1). Parental CMA demonstrated
that both deletions were de novo.
Discussion
Interstitial deletions on 11q are rare and the genotype-
phenotype study had been hindered by the small number
of cases reported and a lack of sufficient details about
patient’s clinical phenotype. So far there are only 11
interstitial deletion cases at the 11q23.3-q25 region have
been reported (Additional file 1: Table S1). Chromosome
microarray data were available for eight of them. Guerin
et al. reported a patient with a 2.899 Mb interstitial dele-
tion at 11q24.2-q24.3, presented with trigonocephaly,
hypertelorism and deep-set eyes [4]; Taoyun Ji et al. re-
ported a patient with a 4.11 Mb interstitial deletion at
11q25, presented with severe DD, microcephaly and
some facial dysmorphism [5]; Tyson et al. described a
patient with a 4.74 Mb deletion at 11q24.2q24.3, pre-
sented with macrocephaly, ID and abnormal MRI [11];
SO J et al. reported a woman with a 3.162 Mb interstitial
deletion at 11q24.2-q24.3, presented with periventricular
nodular heterotopia and transverse limb reduction defect
[13]; Yamamoto et al. identified a 20-month-old boy
with a 5.3 Mb interstitial deletion at 11q23.3q24.2 and
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presented with white matter abnormalities, prenatal
macrocephaly and mild developmental delay [14]. Two
patients reported here added to this list. P1 presented
with short stature, DD/ID, relative microcephaly, sleep-
ing disorder, some dysmorphic features and P2 exhibited
mild DD/ID, relative macrocephaly, mild hypertelorism.
A summary of the clinical features of the eight previ-
ously reported patients with 11q23-qter interstitial dele-
tions and two present cases is listed in Table 1. The
prevalence of phenotype among these interstitial dele-
tion patients can not be quantified for the small number,
but the summarization collectively support the notion
that Jacobsen syndrome is a contiguous gene deletion
syndrome where multiple genes (regions) involved
within the deletion region play roles to the syndromic
phenotypes.
DD/ID is a consistent feature of JBS. It is also a common
feature of patients with 11q interstitial deletions (Table 1).
Taoyun Ji et al. proposed a critical region for DD/ID near
the telomere defined by a 4.1 Mb deletion (case 3 in Fig. 2)
[5]. The deletion detected in our P2 is the smallest in size,
it overlaps with deletions detected in case 1 [13] and 4
[11]. All three cases had the clinical presentation of DD/
ID, based on this observation, we propose a novel DD/ID
locus at 11q24.2 (chr11:124635144–125390604). Similarly,
the deletion detected in our P1 may define another novel
DD/ID locus at 11q23.3-q24.1 (chr11: 120410050–
122085906). Thus there are multiple loci on 11q that the
haploinsufficiency of each region is likely associated with
DD/ID.
It is interesting to note that patient 1 exhibited the
characteristic features of jactatio capitis nocturna, also
known as rhythmic movement disorder (RMD). Most of
RMD will spontaneously resolve by 4 years of age [15].
Our patient’s condition had improved but not resolved
entirely at age 5. The underlying cause of RMD is cur-
rently unknown, the deletion in P1 may provide a clue
for investigating the molecular mechanism of RMD. 13
RefSeq genes including 10 OMIM genes (GRIK4, LRRC35,
TECTA, SC5DL, SORL1, MIR100HG, MIR125B1, BLID,
MIRLET7A2 and MIR100) are involved in the deletion.
But it is unclear which gene or genes are likely responsible
for the sleeping disorder. GRIK4 (OMIM #600282) en-
codes a protein that belongs to the glutamate-gated ionic
channel family. Glutamate functions as the major excita-
tory neurotransmitter in the central nervous system
through activation of ligand-gated ion channels and G
protein-coupled membrane receptors. Takenouchi T et al.
and Pickard BS et al. suggested that the haploinsufficiency
of GRIK4 was related to DD, mental retardation, schizo-
phrenia and bipolar disorder [16, 17]. The developmental
delay present in our patient may be explained by the
GRIK4 deletion.
The deletion interval in P2 encompassed 6 OMIM
genes (ROBO3, ROBO4, HEPACAM, HEPN1, PKNOX2
and FEZ1). Sequence variants in HEPACAM (OMIM
Fig. 1 a The deletion (shaded in red) at 11q23.3-q24.1 in P1 detected by Agilent 4X180K array. b The facial features of P2. Large forehead, mild
hypertelorism, low nasal bridge, thin upper lip and strabismus. The illumina array detected a small deletion (red rectangle) at 11q24.2
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#611642) have been shown to cause Megalencephalic
leukoencephalopathy with subcortical cysts 2A (an auto-
somal recessive form MLC2A, OMIM #613925) and 2B
(an autosomal dominant form MLC2B, OMIM #613926),
both of which are characterized with macrocephaly, ab-
normal MRI and variable degree of intellectual disability
[18–20]. The clinical presentation of the autosomal form
is milder, some features improve with age. Recently hap-
loinsufficiency of HEPACAM was considered as a cause of
two patients with heterozygous deletion at 11q23.3q24.2
interstitial deletion 11q24 and clinical features of MLC
[14]. P2 was presented with relative macrocephaly, abnor-
mal MRI mild developmental delay and seizure, which is
not inconsistent with MLC2B. The much smaller deletion
detected in P2 overlap with the interstitial deletion in pa-
tient 2 of Yamamoto’s report. The smallest overlapping re-
gion between this two cases can exclude the involvement
of FEZ1 (OMIM #604825) gene which plays a role in
axonal outgrowth and has been proposed as a candidate
gene for abnormal MRI by Tyson et al. [11].
Fig. 2 Schematic representation referred to interstitial deletion at 11q23-qter region cases reported (UCSC Genome Browser, hg19)
Table 1 Summary of clinical features of the eight patients with 11q23-qter interstitial deletions and our present cases
Clinical Findings Previously cases P1 P2
Number 8 1 1
Region 11q23-q25 11q23.3q24. 11q24.2
Deletion size (Mb) 2.89–12.8 1.6 0.76
Gender 3 m/5f f m
Age Ranges from newborn to adult 4 years 10 months
Birth weight Low-normal ~15thpercentile 25–50th percentile
Hypotonia - + -
Macrocephaly 2 - relative macrocephaly
Microcephaly 2 relative microcephaly -
Trigonocephaly 1 - -
Prominent forehead 1 + -
Hypertelorism 2 mild mild
Palpebral fissure anomalies 4 + -
Ear anomalies 4 - -
Nasal anomalies 3 + +
Mouth anomalies 3 + +
Limb anomalies 2 + -
Cardiovascular anomalies 4 - -
Hematological anomalies 3 - -
Developmental delay/intellectual disability 6 + +
Social interaction difficulties 2 - NA
Clinical findings: +, present; −, absent, f female, m male, NA not applicable
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Conclusions
In summary, we described two rare interstitial de novo
deletions in JBS region. ID/DD is a shared feature with
JBS, supporting the notion that Jacobsen syndrome is a
true contiguous gene deletion syndrome and critical re-
gions of ID/DD exist in different regions of 11q ter-
minal. Our study further defined a smallest critical
region associate with DD/ID. Each interstitial deletion
also presented with its unique features and suggested
distinct novel genomic imbalance disorder.
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